| Verified against primary record | |
| Follow-up asymmetry | A domestic surgeon is responsible for follow-up; an overseas clinic may not provide it[1] |
|---|---|
| Flying after surgery | Avoid flying for 5 to 7 days after breast surgery or liposuction, 7 to 10 after facial procedures[1] |
| Measured deaths | 25 fat embolism deaths after one procedure in one region, 2010 to 2022, from autopsy records[2] |
| Records read | National health service guidance and the mortality study, 30 September 2026 |
| Independently reported | |
| Mortality rate | The circulating rate is a surgeon survey estimate; the denominator is unknown[2] |
| Bands apply only to the rows beneath them. Two widely quoted survey figures about this sector are deliberately excluded, for the reasons given in the sourcing note. | |
Cosmetic surgery tourism is travel abroad for aesthetic surgical procedures. It is the sector most associated in public discussion with harm, and the sector where the published numbers about harm are weakest. Both halves of that sentence are worth taking seriously.
The official position
Britain’s national health service publishes guidance on cosmetic surgery abroad which begins from a point often lost in the discussion: no surgery is risk-free, and complications can happen after an operation at home as well as overseas. Its specific concerns are structural rather than clinical. After an operation in the United Kingdom it is the surgeon’s responsibility to provide follow-up treatment, whereas overseas clinics may not provide follow-up at all, or may not provide it to the same standard, and the patient may have no domestic healthcare professional to turn to if problems arise. Standards and qualifications abroad may differ, and the guidance advises checking how surgeons and clinics are regulated in the chosen country and how those standards are enforced.[1]
On the journey itself it advises avoiding flying for five to seven days after breast surgery or liposuction and seven to ten days after facial procedures, because of the risk of blood clots.[1] British government travel guidance adds that most travel insurance policies will be invalidated by planned treatment abroad, that the surgeon consulted should be confirmed as the surgeon who will operate, and that a full medical report in English should be obtained to bring home.[3]
The health service guidance carries a review date that has now passed, and does not state whether the domestic system will treat complications arising abroad.
The deadliest procedure claim
Gluteal fat grafting is routinely described as the deadliest cosmetic procedure, on the strength of a mortality rate. Tracing that rate is instructive. A 2023 study in a plastic surgery journal examined fat embolism deaths after the procedure in South Florida and identified 25 such deaths between 2010 and 2022 from autopsy and medical examiner records.[2] Those 25 deaths are measured.
The rate is not. The widely quoted figures come from voluntary surveys of surgical society members: a 2017 survey produced a range between one death in 2,351 procedures and one in 6,241, and a 2019 survey produced one in 14,921, which if accurate would have made the procedure safer than abdominoplasty. The 2023 authors demonstrate that the surveys undercount. The 2019 survey reported two fatal embolism cases nationally in the preceding 24 months, while at least eight autopsy reports documented such deaths in South Florida alone over the same period.[2]
Both the numerator and the denominator of that rate come from surgeons reporting on themselves, and the authors state the structural reason it cannot be complete: many of these procedures are performed in high-volume, budget clinics that do not report their numbers. The apparent improvement in safety between the two surveys is therefore a change between two voluntary returns, not a demonstrated fall in risk. The honest formulation is that deaths have been measured and the rate has not.
What is not counted
No national count of complications presenting at home after cosmetic surgery abroad was located for this entry, and no official statistic on cosmetic procedures performed on foreign patients in any major destination country was obtained. Figures circulating for destination-country volumes come overwhelmingly from commercial and trade sources and should be treated as such until traced to a statistical authority.
See also
- Dental tourism, the neighbouring sector with the same follow-up problem
- Medical spa tourism, the non-surgical end of the same market
- Elective medical travel, the planning category this sits in
- Medical tourism facilitators, who arrange much of this travel
References
- National Health Service, United Kingdom. Cosmetic surgery abroad. Last reviewed 14 December 2022, review date since passed. Verified against primary record: national health service guidance opened and read. Retrieved 30 September 2026.
- Pazmino P, Garcia O Jr. Brazilian Butt Lift-Associated Mortality: The South Florida Experience. Aesthetic Surgery Journal, vol. 43, no. 2, February 2023, pp. 162 to 178; study period January 2010 to April 2022. Independently reported: peer-reviewed primary study using medical examiner records. Retrieved 30 September 2026.
- Foreign, Commonwealth and Development Office, United Kingdom. Surgery abroad? Cut out the risk. Page carries no date. Verified against primary record: government travel campaign guidance opened and read. Retrieved 30 September 2026.
Sourcing note: the health service guidance, the government travel guidance and the mortality study were opened and read on 30 September 2026. The 25 deaths are presented as measured and the mortality rate as survey-derived, because the study that established the deaths also demonstrates that the rate undercounts them. Two figures common in writing on this sector are deliberately excluded: a survey finding that a large majority would consider travelling abroad for cosmetic surgery, which measures hypothetical intent rather than behaviour, and a proportion of clinicians reporting that they had seen complications, which is a survey of practitioners with no patient denominator and cannot be converted into a complication rate.